Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |